C.M. Bidwell & Associates’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-105	Closed	-$646	–	510
2025 Q4	$646	Buy	+105	New	+$761	﹤0.01%	454
2018 Q4	–	Sell	-4,425	Closed	-$204K	–	439
2018 Q3	$204K	Buy	4,425 +1,645	+59%	+$73.1K	0.19%	134
2018 Q2	$104K	Buy	+2,780	New	+$93.9K	0.1%	180
2016 Q2	–	Sell	-3,950	Closed	-$148K	–	291
2016 Q1	$148K	Buy	+3,950	New	+$149K	0.04%	203
2014 Q4	–	Sell	-8,425	Closed	-$325K	–	234
2014 Q3	$325K	Hold	8,425	–	–	0.08%	111
2014 Q2	$328K	Hold	8,425	–	–	0.07%	108
2014 Q1	$288K	Buy	+8,425	New	+$261K	0.07%	117
2013 Q4	–	Sell	-88,520	Closed	-$2.08M	–	240
2013 Q3	$2.08M	Sell	88,520 -505	-0.6%	-$14.3K	0.57%	86
2013 Q2	$2.39M	Buy	+89,025	New	+$2.58M	0.7%	75